Dechra Pharmaceuticals
Pharmaceuticals
DPH.L
GBX 3,264 (1.6)%
Share price
$ 4.4 bn
Market Cap
$ 5.1 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Dechra Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 12 Kt (+0.57/+4.9% y-o-y). At the sime time, carbon intensity declined to 16 t (-1.8 /-10.1% y-o-y).
Dechra Pharmaceuticals's Scope 3 emissions was down at 1.9 Kt (
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.
Copyright © 2022 Exerica. All rights reserved.